牛牛AI助理已提取核心訊息
Steven P. Coen, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), was involved in a transaction on March 7, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The relationship of Coen to the issuer was noted as 'See remarks,' suggesting a need to refer to additional documentation for clarification.
Steven P. Coen, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), was involved in a transaction on March 7, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The relationship of Coen to the issuer was noted as 'See remarks,' suggesting a need to refer to additional documentation for clarification.
與銀杏生物工程控股有限公司（交易代碼DNA.US）相關的史蒂芬·科恩於2024年3月7日參與了一筆交易。公告中未披露交易的具體細節，包括行動類型、狀態、股份數量、股票性質、交易價格和交易後的持股。科恩與發行人的關係被認爲是 “見備註”，這表明需要參考其他文件進行澄清。
與銀杏生物工程控股有限公司（交易代碼DNA.US）相關的史蒂芬·科恩於2024年3月7日參與了一筆交易。公告中未披露交易的具體細節，包括行動類型、狀態、股份數量、股票性質、交易價格和交易後的持股。科恩與發行人的關係被認爲是 “見備註”，這表明需要參考其他文件進行澄清。
有用
沒用